Yvonne Katsande and Dr. Nicolas Hulscher Discuss Pfizer’s Controversial Practices: “Pfizer Operates Like a Criminal Enterprise”
In a compelling interview with Yvonne Katsande, Dr. Nicolas Hulscher, an Epidemiologist and Foundation Administrator at the McCullough Foundation, raised significant concerns regarding Pfizer and its role in the COVID-19 pandemic. Dr. Hulscher began by boldly asserting that Pfizer operates “like a criminal enterprise”, citing the company’s history of legal issues, including hefty fines for illegal marketing practices. He argued that Pfizer’s business model, particularly during the rollout of the COVID-19 vaccine, seemed to prioritize profits over public health, raising serious ethical concerns about the company’s practices.
The conversation broadened to address the potential connection between electromagnetic fields (EMFs) such as those emitted by 5G and Wi-Fi and the pandemic. Dr. Hulscher pointed out that the early COVID-19 outbreaks in China coincided with the initial rollout of 5G, suggesting that EMFs might have made people more vulnerable to the virus. He proposed that these electromagnetic fields, in combination with the effects of the vaccines, could have heightened people’s susceptibility to illness.
A particularly controversial issue that emerged was the use of lipid nanoparticles in mRNA vaccines, elaborating that these nanoparticles, designed to deliver the mRNA into cells, can accumulate in organs such as the heart and liver raising concerns about the long-term consequences of this accumulation and called for more research into the safety of these nanoparticles.
Another intriguing part of the conversation involved the claim that nicotine could act as an antidote to COVID-19. Studies that suggested nicotine might interfere with the virus’s ability to enter cells, but he cautioned against oversimplifying this as a cure.
The conversation turned to the broader issue of vaccine safety and the growing concerns around vaccine hesitancy. Observation that declining vaccination rates reflect a significant loss of trust in the safety and efficacy of vaccines, particularly after the rushed rollout of the COVID-19 vaccine. The erosion of trust is a critical issue for public health moving forward.
The interview sparked important conversations around the role of pharmaceutical companies, the safety of vaccines, and the broader ethics surrounding public health initiatives, making it clear that these issues will require ongoing scrutiny and a more transparent approach to policy-making in the future.
Watch Full Interview Here:
